Dr. Ronen Adato leverages his extensive background in nanotechnology and electrical engineering in providing patent protection to a variety of academic and business clients.
As a postdoctoral fellow in Boston University’s Department of Electrical and Computer Engineering (with additional appointments in the Photonics Center and Rafik B. Hariri Institute for Computing and Computational Science and Engineering), Ronen focused his research on creating nanophotonic and computational tools for sensing, microscopy, and spectroscopy. He oversaw projects aimed at developing new techniques for characterizing semiconductor integrated circuits for failure analysis and security testing applications. Ronen also secured funding for and managed the development of a multi-user near-field microscopy facility as part of the National Science Foundation Major Research Instrumentation program. Ronen’s PhD research focused on development of nanoscale antennas to enhance the sensitivity of infrared absorption spectroscopy measurements used for study of protein structure-function relationships and disease diagnostics.
- Development and prosecution of patent portfolios for start-ups, venture-backed companies, public companies, and research institutions.
- Competitive landscape searching and analyses.
- IP diligence support for financing transactions, mergers, and acquisitions.
- Assists patent prosecution and litigation teams in AIA post grant review proceedings.
Publications and Presentations
- “Rapid mapping of digital integrated circuit logic gates via multi-spectral backside imaging,” first author, arXiv preprint, 2016.
- “Physical modeling of interference enhanced imaging and characterization of single nanoparticles,” co-author, Optics Express, 2016.
- “Integrated nanoantenna labels for rapid security testing of semiconductor circuits,” speaker, Optical Society of America Frontiers in Optics Meeting, 2015.
- "Detecting Hardware Trojans using backside optimal imaging of embedded watermarks," co-author, Design Automation Conference, 2015.
- “Engineering mid-infrared nanoantennas for surface enhanced infrared absorption spectroscopy,” first author, Materials Today, 2015.
- “In-situ ultra-sensitive infrared spectroscopy of biomolecule interactions in real-time with plasmonic nanoantennas,” first author, Nature Communications.
- “Ultra-sensitive vibrational spectroscopy of protein monolayers with plasmonic nanoantenna arrays,” first author, Proceedings of the National Academy of Sciences, USA.
Education & Credentials
- Boston College Law School
- JD, 2022
- Boston University
- PhD, 2013, Electrical and Computer Engineering
- The University of Alabama in Huntsville
- MS, 2008, Electrical Engineering
- Duke University
- BS, 2005, Electrical Engineering
Choate was privileged to provide IP diligence counsel to BioNTech in support of its recent acquisition of InstaDeep. The companies have described this acquisition as building on a successful track record of increasing collaboration between them, and as enabling creation of a fully integrated, enterprise-wide capability to discover, design and develop next-generation immunotherapies at scale by leveraging artificial intelligence (AI) and machine learning (ML) technologies across BioNTech’s therapeutic platforms and operations.
Choate assisted Immuneering Corporation with handling its platform IP in its $112.5M IPO. A portion of the proceeds from the IPO will be used to bring Immuneering’s lead candidate, a dual-MEK inhibitor dubbed IMM-1-104, into the clinic for advanced solid tumors in patients harboring RAS mutations.
Choate advised Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and artificial intelligence to find, fight, and follow cancer, and EXINI, a wholly owned subsidiary of Progenics, in its transfer agreement with FUJIFILM Toyama Chemical Co, Ltd. (FFTC) for the rights to Progenics’ Automated Bone Scan Index (aBSI) product in Japan for use under the name BONENAVI. BONENAVI has been licensed to FFTC for use in Japan since 2011.